“We believe we will offer in a year’s time a complete cure for cancer,” Dan Aridor, of AEBi, told the news outlet.

The company’s CEO, Dr. Ilan Morad, said MuTaTo also works to target cancer stem cells, eliminating the chances of recurrence, with Aridor claiming that it will be effective from “Day 1” and cause “no or minimal side effects at a much lower cost than most other treatments.”

“Our solution will be both generic and personal,” Aridor said.

But Dr. Ben Neel, director of Perlmutter Cancer Center at NYU Langone Health, is skeptical, telling Fox News via email: “Of course, curing cancer is the goal of everyone who comes to work every day at a cancer center — and if this company does, in fact, cure cancer, they will have my congratulations and thanks. But cancer is multiple diseases, and it is highly unlikely that this company has found a ‘cure’ for cancer, anymore than there is a single cure for infections.”

videoPlayerId=3c6c9f5a3

The treatment has not been tested in humans yet, although Aridor said it has shown success in mice and is nearing the clinical trial stage.

Said Neel, “More likely, this claim is yet another in a long line of spurious, irresponsible and ultimately cruel false promises for cancer patients.”

Categorías: Life

Featured Videos